
Precision Medicine Podcast · Trapelo
Advancing Prostate Cancer Care with Dr. William Oh: Precision Medicine, Diagnostics and Advocacy (Part 2)
·33 min·5 clips
As heard by us
A measured look at prostate cancer precision medicine, with promise ahead but few easy answers.
The episode takes a careful, practical look at prostate cancer care, with Dr. William Oh explaining why immunotherapy has fallen short so far and why only about one or two percent of patients are candidates for pembrolizumab as a single agent.
Why you'd press play
Want a clear read on where prostate cancer precision medicine is helping, and where it still falls short?
Listen to the show on